Literature DB >> 25976161

Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature.

Amanda M Brandow1,2,3, Rebecca A Farley1,2, Julie A Panepinto1,2,3.   

Abstract

Novel insights into the neurobiology of sickle cell disease (SCD) pain have recently been discovered. We systematically reviewed the literature focusing on original research that examined the biology of pain in SCD and/or addressed assessment or treatment of neuropathic pain in SCD. This review of 15 articles that met inclusion criteria provides epidemiological, basic, and clinical data that support central and/or peripheral nervous system abnormalities likely contribute to sickle cell pain. Continued basic and clinical investigation into pain neurobiology is imperative to translate these discoveries into novel ways to assess and treat neuropathic pain and decrease patient suffering.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  neurobiology; neuropathic pain; pain; sickle cell disease

Mesh:

Year:  2015        PMID: 25976161      PMCID: PMC4515148          DOI: 10.1002/pbc.25574

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  22 in total

Review 1.  Peripheral and central mechanisms of cutaneous hyperalgesia.

Authors:  R D Treede; R A Meyer; S N Raja; J N Campbell
Journal:  Prog Neurobiol       Date:  1992       Impact factor: 11.685

Review 2.  Diagnosis and management of neuropathic pain.

Authors:  R Freynhagen; M I Bennett
Journal:  BMJ       Date:  2009-08-12

3.  Safety and Utility of Quantitative Sensory Testing among Adults with Sickle Cell Disease: Indicators of Neuropathic Pain?

Authors:  Miriam O Ezenwa; Robert E Molokie; Zaijie Jim Wang; Yingwei Yao; Marie L Suarez; Cherese Pullum; Judith M Schlaeger; Roger B Fillingim; Diana J Wilkie
Journal:  Pain Pract       Date:  2015-01-12       Impact factor: 3.183

4.  Cutaneous sensory abnormalities in children and adolescents with complex regional pain syndromes.

Authors:  Navil F Sethna; Petra M Meier; David Zurakowski; Charles B Berde
Journal:  Pain       Date:  2007-02-27       Impact factor: 6.961

5.  Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia.

Authors:  Yan Chen; Cheng Yang; Zaijie Jim Wang
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

6.  Mast cell activation contributes to sickle cell pathobiology and pain in mice.

Authors:  Lucile Vincent; Derek Vang; Julia Nguyen; Mihir Gupta; Kathryn Luk; Marna E Ericson; Donald A Simone; Kalpna Gupta
Journal:  Blood       Date:  2013-06-17       Impact factor: 22.113

7.  Reversal of chronic inflammatory pain by acute inhibition of Ca2+/calmodulin-dependent protein kinase II.

Authors:  Fang Luo; Cheng Yang; Yan Chen; Pradeep Shukla; Lei Tang; Lili X Wang; Zaijie Jim Wang
Journal:  J Pharmacol Exp Ther       Date:  2008-01-04       Impact factor: 4.030

8.  Acute inhibition of Ca2+/calmodulin-dependent protein kinase II reverses experimental neuropathic pain in mice.

Authors:  Yan Chen; Fang Luo; Cheng Yang; Chelsea M Kirkmire; Zaijie Jim Wang
Journal:  J Pharmacol Exp Ther       Date:  2009-05-28       Impact factor: 4.030

9.  Patients with sickle cell disease have increased sensitivity to cold and heat.

Authors:  Amanda M Brandow; Cheryl L Stucky; Cheryl A Hillery; Raymond G Hoffmann; Julie A Panepinto
Journal:  Am J Hematol       Date:  2012-10-31       Impact factor: 10.047

Review 10.  Review of measures of neuropathic pain.

Authors:  Mark P Jensen
Journal:  Curr Pain Headache Rep       Date:  2006-06
View more
  26 in total

Review 1.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

2.  Clinical Interpretation of Quantitative Sensory Testing as a Measure of Pain Sensitivity in Patients With Sickle Cell Disease.

Authors:  Amanda M Brandow; Julie A Panepinto
Journal:  J Pediatr Hematol Oncol       Date:  2016-05       Impact factor: 1.289

Review 3.  Psychological Predictors of Pain in Children and Adolescents With Sickle Cell Disease: A Scoping Review.

Authors:  Clare Donohoe; Ellen Lavoie Smith
Journal:  J Pediatr Oncol Nurs       Date:  2018-12-19       Impact factor: 1.636

4.  Effect of chronic opioid therapy on pain and survival in a humanized mouse model of sickle cell disease.

Authors:  Huy Tran; Varun Sagi; Waogwende Leonce Song-Naba; Ying Wang; Aditya Mittal; Yann Lamarre; Lei Zhang; Kalpna Gupta
Journal:  Blood Adv       Date:  2019-03-26

Review 5.  Mast cell-neural interactions contribute to pain and itch.

Authors:  Kalpna Gupta; Ilkka T Harvima
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

Review 6.  Integrative approaches to treating pain in sickle cell disease: Pre-clinical and clinical evidence.

Authors:  Varun Sagi; Donovan A Argueta; Stacy Kiven; Kalpna Gupta
Journal:  Complement Ther Med       Date:  2020-05-11       Impact factor: 2.446

Review 7.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 8.  Improving Emergency Department-Based Care of Sickle Cell Pain.

Authors:  Jeffrey A Glassberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 9.  Pain-measurement tools in sickle cell disease: where are we now?

Authors:  Deepika S Darbari; Amanda M Brandow
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

10.  Red blood cell transfusion therapy for sickle cell patients with frequent painful events.

Authors:  Lee M Hilliard; Varsha Kulkarni; Bisakha Sen; Cathy Caldwell; Christina Bemrich-Stolz; Thomas H Howard; Amanda Brandow; Emily Waite; Jeffrey D Lebensburger
Journal:  Pediatr Blood Cancer       Date:  2018-08-27       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.